Repligen (RGEN) Change in Accured Expenses (2010 - 2026)

Repligen (RGEN) has 17 years of Change in Accured Expenses data on file, last reported at -$12.7 million in Q1 2026.

• On a quarterly basis, Change in Accured Expenses fell 800.33% year-over-year to -$12.7 million in Q1 2026; TTM through Mar 2026 was -$2.6 million, a 153.7% decrease from a year earlier, with the FY2025 full-year figure at $11.8 million, up 93.47% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$12.7 million, down from $2.2 million in the prior quarter.
• Over the last five years, Change in Accured Expenses for RGEN reached as high as $12.6 million in Q3 2025 and fell as low as -$12.7 million in Q1 2026.
• Historically, Change in Accured Expenses has averaged -$1.1 million across 5 years, with a median of -$721000.0 in 2024.
• Across the five-year window, Change in Accured Expenses jumped 516.24% in 2024 and sank 800.33% in 2026, its largest moves.
• Year by year, Change in Accured Expenses stood at -$5.1 million in 2022, then sank by 77.87% to -$9.0 million in 2023, then jumped by 108.29% to $746000.0 in 2024, then surged by 192.76% to $2.2 million in 2025, then sank by 679.44% to -$12.7 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$12.7 million in Q1 2026, $2.2 million in Q4 2025, and $12.6 million in Q3 2025.